Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegifn/RBV) re-treatment in hepatitis C patients with prior non-response to pegifn/RBV: Week 24 results

被引:19
作者
Afdhal, N.
O'Brien, C.
Godofsky, E.
Rodriguez-Torres, M.
Pappas, S. C.
Pockros, P.
Lawitz, E.
Bzowej, N.
Rustgi, V.
Sulkowski, M.
Sherman, K.
Jacobson, I.
Chao, G.
Knox, S.
Pietropaolo, K.
Brown, N.
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Bach & Godofsky, Bradenton, FL USA
[4] Fdn Invest Diego, Santurce, PR USA
[5] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[6] Scripps Clin, La Jolla, CA USA
[7] Alamo Med Res, San Antonio, TX USA
[8] Calif Pacific Med Ctr, San Francisco, CA USA
[9] Metropolitan Res, Fairfax, VA USA
[10] Univ Cincinnati, Med Ctr, Cincinnati, OH USA
[11] Cornell Univ, Weill Med Coll, New York, NY USA
[12] Idenix Pharmaceut, Cambridge, MA USA
[13] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
D O I
10.1016/S0168-8278(06)80040-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
39
引用
收藏
页码:S19 / S19
页数:1
相关论文
empty
未找到相关数据